Reviva is a late-stage biopharmaceutical company that discovers, develops, and seeks to commercialize next-generation therapeutics for diseases representing unmet medical needs and burdens to society, ...

Phase 1/2 data show improvements across all domains and confirm that Phase 3 Aspire study is amply powered to establish ...

Saturday, Summit City will honor veterans in the annual Veterans Day Parade. Starting at 11 a.m. the parade opens at the ...

AppLovin's stock had its best day ever Thursday, rising 46% following the company's latest earnings, and it gained another 18% in Friday's session. That could reflect investor perception of how far ...

Recruiting patients for rare disease trials is akin to finding a needle in a haystack, with challenges such as geographical ...

A great pick for aggressive investors Keith Speights (Summit Therapeutics): Unlike AstraZeneca and Exelixis, Summit Therapeutics doesn't have any products on the market yet. Clinical-stage biotech ...

Nammi Therapeutics, Inc. (Nammi), a clinical stage immuno-oncology company with a diverse pipeline created with the Masked-Immunocytokine (MIC) and Nammisome platforms, announces dosing of the first ...

Regula, a global developer of forensic devices and identity verification solutions, just hosted its Partner Summit in Dubai, bringing together industry players from 30 countries. With presentations ...

First patient dosed with first-in-class SMARCA2(BRM) selective inhibitor FHD-909 (LY4050784) in Phase 1 trial with primary target population in SMARCA4(BRG1) mutated NSCLC Topline Phase 1 dose ...

Biopharma stocks are rarely suitable for short-term investing, so hold onto them. Summit Therapeutics may have a powerful new ...

The Citizens JMP Hematology and Oncology Summit, taking place virtually on Monday, December 2, 2024 at 1:30 p.m. ET The ...

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> ...